Abstract
Calcium may be considered as the ultimate intracellular messenger of the signals received at the level of smooth muscle pericellular membrane to produce a change in the active tone. The calcium responsible for the increase in free cytoplasmic levels is potentially available from the intracellular space and also from several compartments having various affinities for calcium. Several cellular mechanisms maintain the calcium gradient across the plasmalemmal membrane. They are associated with the plasma membrane itself and with intracellular organelles. Differences between muscles are to some extent due to differences in the importance and the properties of the different mechanisms operating at rest and during activation. Pharmacologic agents influence calcium movements by acting on those mechanisms responsible for calcium homeostasis at the cellular level (Table 1). Understanding of the mode of action of those agents requires a proper analysis of the mechanisms of this calcium homeostasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alosachie I, Godfraind T (1986) Role of cyclic GMP in the modulation by endothelium of the adrenolytic action of prazosin in rat isolated aorta. Br J Pharmacol 80:525–532
Baker PF, Blaustein MP, Hodgkin AL, Steinhard RA (1969) The influence of Ca on Na efflux in squid axons. J Physiol (Lond) 200:431–458
Batra S (1985) Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry. Br J Pharmacol 85:767–774
Bolger GT, Gengo PJ, Luchowski EM, Siegel H, Toggle DJ, Janis RA (1982) High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. Biochem Biophys Res Commun 104:1604–1609
Bolger GT, Gengo P, Klockowski R, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291–309
Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718
Brading AF (1981) Ionic distribution and mechanism of transmembrane ion movements in smooth muscle. In: Bülbring EE, Brading AF, Jones AW, Tomita T (eds) Smooth muscle. Arnold, London, pp 65–92
Broekaert A, Godfraind T (1979) A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries. Eur J Pharmacol 53:281–288
Caroni P, Carafoli E (1983) The regulation of the Na+-Ca2+ exchanger of heart sarcolemma. Eur J Biochem 132:451–460
Caroni P, Reinlib L, Carafoli E (1980) Charge movements during the Na+-Ca2+ exchange in heart sarcolemmal vesicles. Proc Natl Acad Sci (USA) 77:6354–6358
Casteels R, van Breemen C (1975) Active and passive Ca2+ fluxes across cell membranes of the guinea-pig taenia coli. Pflügers Arch 359:197–207
Cauvin C, Saida K, van Breemen C (1982) Effects of Ca antagonists on Ca fluxes in resistance vessels. J Cardiovasc Pharmacol 4:S287–290
De Pover A, Matlib MA, Lee SW, Dube GP, Grupp IL, Grupp G, Schwartz A (1982) Specific binding [3H] nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun 108:110–117
Egleme C, Godfraind T, Miller RC (1984) Enhanced responsiveness of rat isolated aorta to Clonidine after removal of the endothelial cell. Br J Pharmacol 81:16–18
Fabiato A, Fabiato F (1979) Calcium and cardiac excitation contraction coupling. Ann Rev Physiol 41:473–484
Fleckenstein A (1973) Calcium antagonism in heart and smooth muscle. Wiley, New York
Furchgott RF (1984) The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 24:175–197
Godfraind T (1976) Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. J Physiol (Lond) 260:21–35
Godfraind T (1983) Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. J Pharmacol Exp Ther 224:443–450
Godfraind T (1985) Cellular and subcellular approaches to the mechanism of action of calcium antagonists. In: Rubin RP, Weiss GB, Putney JW (eds) Calcium in biological systems. Plenum, New York, pp 411–421
Godfraind T (1986 a) Calcium entry blockade and excitation contraction coupling in the cardiovascular systems (with an attempt of pharmacological classification). Acta Pharmacol Toxicol 58 (Suppl 2): 5–30
Godfraind T (1986 b) EDRF and cyclic GMP control gating of receptor-operated calcium channels in vascular smooth muscle. Eur J Pharmacol 126:341–343
Godfraind T, Dieu D (1981) The inhibition by fluanrizine on the norepinephrine evoked contraction and calcium influx in rat aorta and mesenteric arteries. J Pharmacol Exp Ther 217:510–515
Godfraind T, Kaba A (1969) Blockade or reversal of contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br J Pharmacol 36:549–560
Godfraind T, Miller RC (1983) Specificity of action of Ca+ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries. Circ Res 52 (Suppl 1):81–91
Godfraind T, Polster P (1968) Etude comparative de médicaments inhibant la réponse contractile de vaisseaux isolés d’origine humaine et animale. Thérapie 23:1209–1220
Godfraind T, Wibo M (1985) Subcellular localization of [3H]-nitrendipine binding sites in guinea-pig ileal smooth muscle. Br J Pharmacol 85:335–340
Godfraind T, Kaba A, Polster P (1968) Differences in sensitivity of arterial smooth muscle to inhibition of their contractile response to depolarization by potassium. Arch Int Pharmacodyn Ther 172:235–239
Goodfraind T, Finet M, Socrates Lima J, Miller R (1984) Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine. J Pharmacol Exp Ther 230:514–518
Godfraind T, Egleme C, Alosachie I (1985 a) Role of endothelium in the contractile response of rat aorta to alpha-adrenergic agonists. Clin Sci 68:65s–71s
Godfraind T, Egleme C, Wibo M (1985 b) Effects of dihydropyridines on human and animal isolated vessels. In: Fleckenstein A, Breemen C van, Gross R, Hoffmeister F (eds) Cardiovascular effects of dihydropyridine-type calcium antagonists and agonists. Springer, Berlin Heidelberg New York Tokyo, pp 309–325 (Bayer symposium, vol 9)
Godfraind T, Miller RC, Wibo M (1986) Calcium antagonism and calcium entry blockade. Pharmacol Rev 38:321–416
Godfraind-De Becker A, Godfraind T (1980) Calcium transport system: a comparative study in different cells. Int Rev Cytol 67:141–170
Grover AK, Oakes PJ (1985) Calcium channel antagonist binding and pharmacology in rat uterine smooth muscle. Life Sci 37:2187–2192
Hidaka H, Hartshorne DJ (1985) Calmodulin antagonists and cellular physiology. Academic, Orlando, p 543
Hirata M, Itoh T, Kuriyama H (1981) Effects of external cations on calcium efflux from single cells of guinea-pig taenia coli and porcine coronary artery. J Physiol (Lond) 310:321–336
Jim K, Harris A, Rosenberger LB, Triggle DJ (1981) Stereoselective and non-stereoselective effects of D 600 (methoxyverapamil) in smooth muscle preparations. Eur J Pharmacol 76:67–72
Lincoln TM (1983) Effects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta. J Pharmacol Exp Ther 224:100–107
Meisheri KD, van Breemen C (1982) Effects of beta-adrenergic stimulation on calcium movements in rabbit aortic smooth muscle: relation with cyclic AMP. J Physiol (Lond) 331:429–441
Meisheri KD, Hwang O, van Breemen C (1981) Evidence for two separate Ca2+ pathways in smooth muscle-plasmalemma. J Membr Biol 59:19–25
Morel N, Godfraind T (1982) Na-Ca exchange in heart and smooth muscle microsomes. Arch Int Pharmacodyn Ther 258:319–321
Morel N, Godfraind T (1984) Sodium/Calcium exchange in smooth-muscle microsomal fractions. Biochem J 218:421–427
Morel N, Wibo M, Godfraind T (1981) A calmodulin-stimulated Ca2+ pump in rat aorta plasma membranes. Biochim Biophys Acta 644:82–88
Philipson KD, Nishimoto AY (1980) Na+-Ca2+ exchange is affected by membrane potential in cardiac sarcolemmal vesicles. J Biol Chem 255:6880–6882
Pitts BJ (1979) Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. J Biol Chem 254:6232–6235
Reeves JP, Sutko JL (1979) Sodium-calcium ion exchange in cardiac membrane vesicles. Proc Natl Acad Sci (USA) 76:590–594
Reuter H (1974) Exchange of calcium ions in the mammalian myocardium. Mechanisms and physiological significance. Circ Res 34:599–609
Reuter H (1982) Na-Ca countertransport in cardiac muscle. In: Martonosi A (ed) Membrane and transport, vol 1. Plenum, New York, pp 623–631
Saida K, van Breemen C (1983) Mechanism of Ca2+ antagonist-induced vasodilation. Intracellular actions. Circ Res 52:137–142
Schatzmann HJ, Vincenzi FF (1969) Calcium movements across the membrane of human red cells. J Physiol (Lond) 201:369
Schramm M, Thomas G, Towart R, Franckowiak G (1983) Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 303:535–537
Somlyo AV, Bond M, Somloy AP, Scarpa A (1985) Inositol trisphosphate-induced calcium release and contraction in vascular smooth muscle. Proc Natl Acad Sci USA 82:5231
Suematsu E, Hirata M, Hashimoto T, Kuriyama H (1984) Inositol 1,4,5-trisphosphate releases Ca2+ from intracellular store sites in skinned single cells of porcine coronary artery. Biochem Biophys Res Commun 120:481
Triggle CR, Agrawal DK, Bolger GT, Daniel EE, Kwan CY, Luchowski EM, Triggle DJ (1982) Calcium channel antagonist binding to isolated vascular smooth muscle membranes. Can J Physiol Pharmacol 60:1738–1741
Van Nueten JM (1982) Selectivity of calcium entry blockers. In: Godfraind T, Albertini A, Paoletti R (eds) Calcium modulators. Elsevier, Amsterdam, pp 199–208
Venter JC, Fraser CM, Schaber JS, Jung CY, Bolger S, Triggle DJ (1983) Molecular properties of the slow inward calcium channel. Molecular weight determinations by radiation inactivation and covalent affinity labeling. J Biol Chem 258:9344–9348
Wibo M, Morel N, Godfraind T (1981) Differentiation of Ca2+ pumps linked to plasma membrane and endoplasmic reticulum in the microsomal fraction from intestinal smooth muscle. Biochim Biophys Acta 649:651–660
Williams JA (1980) Regulation of pancreatic acinar cell function by intracellular calcium. Am J Physiol 238:G269–G279
Winquist RJ (1984) Modulators of intracellular calcium. Drug Dev Res 4:241–256
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Godfraind, T. (1988). Pharmacology of Calcium Metabolism in Smooth Muscle. In: Baker, P.F. (eds) Calcium in Drug Actions. Handbook of Experimental Pharmacology, vol 83. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71806-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-71806-9_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71808-3
Online ISBN: 978-3-642-71806-9
eBook Packages: Springer Book Archive